Gene · 259
Papers2,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of Infiltrating Immune Cells and Secretory or Membrane-Associated Proteins in KRAS Lung Adenocarcinoma. | J Immunol Res | 2023 | 36793588 | PubTator, text mining | PubMed |
| Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients. | Mol Biotechnol | 2023 | 36790659 | PubTator, text mining | PubMed |
| Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. | Infect Agent Cancer | 2023 | 36782325 | PubTator, text mining | PubMed |
| Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice. | Int J Mol Sci | 2023 | 36769148 | PubTator, text mining | PubMed |
| Macrophage Phenotyping in Atherosclerosis by Proteomics. | Int J Mol Sci | 2023 | 36768933 | PubTator, text mining | PubMed |
| Cadmium-Induced Proteinuria: Mechanistic Insights from Dose-Effect Analyses. | Int J Mol Sci | 2023 | 36768208 | PubTator, text mining | PubMed |
| Urinary Extracellular Vesicles in Chronic Kidney Disease: From Bench to Bedside? | Diagnostics (Basel) | 2023 | 36766548 | PubTator, text mining | PubMed |
| A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer. | Cancers (Basel) | 2023 | 36765678 | PubTator, text mining | PubMed |
| Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics. | Cancers (Basel) | 2023 | 36765599 | PubTator, text mining | PubMed |
| Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients. | Front Immunol | 2023 | 36761728 | PubTator, text mining | PubMed |
| Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics. | Diabetes Metab Syndr Obes | 2023 | 36760602 | PubTator, text mining | PubMed |
| The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation. | J Neuroinflammation | 2023 | 36759861 | PubTator, text mining | PubMed |
| Consolidation of metabolomic, proteomic, and GWAS data in connective model of schizophrenia. | Sci Rep | 2023 | 36747015 | PubTator, text mining | PubMed |
| Establishment and characterization of canine mammary tumoroids for translational research. | BMC Biol | 2023 | 36737789 | PubTator, text mining | PubMed |
| Proteomics identifies novel biomarkers of synovial joint disease in a canine model of mucopolysaccharidosis I. | Mol Genet Metab | 2023 | 36709534 | PubTator, text mining | PubMed |
| Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIV. | Nat Commun | 2023 | 36693889 | PubTator, text mining | PubMed |
| Text-Mining to Identify Gene Sets Involved in Biocorrosion by Sulfate-Reducing Bacteria: A Semi-Automated Workflow. | Microorganisms | 2023 | 36677411 | PubTator, text mining | PubMed |
| Emerging Biomarkers for Predicting Clinical Outcomes in Patients with Heart Disease. | Life (Basel) | 2023 | 36676179 | PubTator, text mining | PubMed |
| Prediction Models of Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis. | J Clin Med | 2023 | 36675488 | PubTator, text mining | PubMed |
| The Heterogeneous Effects of Formal and Informal Environmental Regulation on Green Technology Innovation-An Empirical Study of 284 Cities in China. | Int J Environ Res Public Health | 2023 | 36674374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259/papers?page=15